Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study
Gait as Predictor of Cognitive Decline, Dementia, and Risk of Falls in MCI. A Cohort Study
Sponsor: Manuel Montero Odasso
Listed as NCT03020381, this observational or N/A phase trial focuses on Alzheimer Disease and Cerebral Atrophy and remains actively recruiting participants. Sponsored by Manuel Montero Odasso, it has been updated 16 times since 2007, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
16 versions recorded-
Apr 2025 — Present [monthly]
Recruiting
-
Jan 2025 — Apr 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
▶ Show 11 earlier versions
-
Feb 2023 — Jan 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Feb 2023 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Recruiting
-
Feb 2019 — Apr 2020 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Dec 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Manuel Montero Odasso
For direct contact, visit the study record on ClinicalTrials.gov .